Executive Series: Virtus Health (VRT) CEO, Sue Channon


Online Stockbroker

 In this short video we discuss VRTs’ full year results, which saw NPAT attributable to ordinary equity holders down 14.6% to $28.1m and included a final dividend 12 cents per share fully franked; VRT’s position in the domestic market where it remains the overall leader with 42.1% share of the Australian eastern states market; The importance of VRT’s diagnostic business where revenue increased by nearly 9% in FY17, delivering an EBITDA improvement over the prior year of 37% driven by the new applications of genetic testing and screening in reproductive medicine.






2 topics

1 stock mentioned

Online Stockbroker
Online Stockbroker

CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...


No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.